UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

FORM 10-Q

 

(Mark One)

 

QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

 

For the quarterly period ended: September 30, 2020

 

Or

 

TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

 

For the transition period from: _____________ to _____________

 

ADVANCED OXYGEN TECHNOLOGIES, INC.

(Exact name of registrant as specified in its charter)

 

Delaware   0-9951   91-1143622
(State or Other Jurisdiction   (Commission   (I.R.S. Employer
of Incorporation)   File Number)   Identification No.)

 

C/O Crossfield, Inc., 653 VT Route 12A, PO Box 189, Randolph, VT 05060

(Address of Principal Executive Offices) (Zip Code)

 

(212) 727-7085

(Registrant’s telephone number, including area code)

 

Title of Class   Trading Symbol   Name of each exchange on which registered
Common Stock, $0.01 Par Value   AOXY   OTC:PINK

 

Securities registered under Section 12(g) of the Exchange Act: Common Stock, par value $.01 per share

 

Indicate by check mark if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Yes ☐    No ☒

 

Indicate by check mark if the registrant is not required to file reports pursuant to section 13 or Section 15(d) of the Act. Yes ☐    No ☒

 

Indicate by check whether the registrant: (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes ☒    No ☐

 

Indicate by check mark whether the registrant has submitted electronically and posted on its corporate Web site, if any, every Interactive Data File required to be submitted and posted pursuant to Rule 405 of Regulation S-T (§ 229.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit and post such files). Yes ☒    No ☐

 

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, or a smaller reporting company. See the definitions of “large accelerated filer”, “an accelerated filer” and “smaller reporting company” in Rule 12b-2 of the Exchange Act.

 

Large Accelerated Filer Accelerated Filer
Non Accelerated Filer Smaller Reporting Company
Emerging Growth Company    

 

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

 

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act. Check one: Yes ☐    No ☒

 

Indicate the number of shares outstanding of each of the issuer’s classes of common stock, as of the last practicable date: As of October 22, 2020, there were 3,292,945 issued and outstanding shares of the registrant’s Common Stock, $.01 par value.

 

Documents incorporated by reference: None.

 

 

 

 

 

 

ADVANCED OXYGEN TECHNOLOGIES, INC.

 

Table of Contents

 

  INDEX   Page  
PART I      
       
Item I: Financial Statements (unaudited)      
  Condensed Consolidated Balance Sheet as of September 30, 2020 (unaudited) and June 30, 2020     1  
  Condensed Consolidated Statement of Operations and Comprehensive Income (Loss) for the three months ended September 30, 2020 and September 30, 2019 (unaudited)     2  
  Condensed Consolidated Statement of Stockholders’ Equity for the three months ended September 30, 2020 and September 30, 2019(unaudited)     3  
  Condensed Consolidated Statement of Cash Flow for the three months ended September 30, 2020 and September 30, 2019 (unaudited)     4  
  Notes to the Condensed Consolidated Financial Statements     5-14  
           
Item 2: Management’s Discussion and Analysis of Financial Condition and Results of Operations     15  
Item 3: Quantitative and Qualitative Disclosures about Market Risk     16  
Item 4: Controls and Procedures     16  
           
PART II        
         
Item 1: Legal Proceedings     17  
Item 2: Unregistered Sales of Equity Securities and Use of Proceeds     17  
Item 3: Defaults Upon Senior Securities     17  
Item 4: Mine Safety Disclosures     17  
Item 5: Other Information     17  
Item 6. Exhibits and Reports on Form 8-K     18  
Signature     19  
EXHIBIT 31.1, 31.2 Certifications of Officers   EX 31  
EXHIBIT 32.1, 32.2 Certifications of Officers   EX 32  
EXHIBIT 101.INS XBRL Instance   EX 101.INS  
EXHIBIT 101.SCH XBRL Taxonomy Extension Schema Document   EX 101.SCH  
EXHIBIT 101.CAL XBRL Taxonomy Extension Calculation Document   EX 101.CAL  
EXHIBIT 101.DEF XBRL Taxonomy Extension Definition Document   EX 101.DEF  
EXHIBIT 101.LAB XBRL Taxonomy Extension Labels Document   EX 101.LAB  
EXHIBIT 101.PRE XBRL Taxonomy Extension Presentation Document   EX 101.PRE  

 

i

 

 

PART 1: FINANCIAL INFORMATION

 

Item I: Condensed Consolidated Financial Statements for the three months ending September 30, 2020 (unaudited).

 

ADVANCED OXYGEN TECHNOLOGIES, INC.

AND SUBSIDIARIES

CONDENSED CONSOLIDATED BALANCE SHEETS

 

   

September 30,

2020

   

June 30,

2020

 
    (Unaudited)        
ASSETS                
CURRENT ASSETS                
Cash   $ 45,589     $ 43,603  
Property tax receivable     1,255       1,202  
Total Current Assets     46,844       44,805  
                 
                 
Property and equipment     636,613       609,250  
TOTAL ASSETS   $ 683,457     $ 654,055  
                 
LIABILITIES AND STOCKHOLDERS’ EQUITY                
CURRENT LIABILITIES                
Accounts payable   $ 3,235     $ -  
Contract liabilities     3,291       3,150  
Taxes payable     42,116       36,030  
Current portion of notes payable     144,983       144,211  
Advances from a related party     120,047       120,271  
Total Current Liabilities     313,672       303,662  
                 
Long Term Liabilities                
     Notes payable, net of current portion     41,798       44,416  
Total Long-term Liabilities     41,798       44,416  
                 
Total Liabilities     355,470       348,078  
                 
STOCKHOLDERS’ EQUITY-                
Convertible preferred stock, Series 2, par value $0.01; authorized 10,000,000 shares; issued and outstanding 5,000 at September 30, 2020 and June 30, 2020     50       50  
Convertible preferred stock, Series 3, par value $0.01; authorized 1,670,000 shares; zero shares issued and outstanding     -       -  
Convertible preferred stock, Series 5; no par value, 1 share authorized, zero shares issued and outstanding, respectively.     -       -  
Common stock, par value $0.01; At September 30, 2020 and June 30, 2020, authorized 60,000,000 shares; issued and outstanding 3,292,945 shares and 3,292,945 shares.     32,929       32,929  
Additional paid-in capital     21,057,116       21,057,116  
Accumulated other comprehensive income     68,714       43,226  
Accumulated deficit     (20,830,822 )     (20,827,344 )
TOTAL STOCKHOLDERS EQUITY     327,987       305,977  
TOTAL LIABILITIES AND STOCKHOLDERS EQUITY   $ 683,457     $ 654,055  

 

See accompanying notes to condensed unaudited consolidated financial statements.

 

1

 

 

ADVANCED OXYGEN TECHNOLOGIES, INC.
AND SUBSIDIARIES
CONDENSED CONSOLIDATED STATEMENT OF OPERATIONS AND COMPREHENSIVE INCOME (LOSS)

(Unaudited)

 

    For the three months ended September 30,  
    2020     2019  
Revenues                
Rent Revenues   $ 10,329     $ 9,329  
Commission Revenue     -       -  
Net Sales   $ 10,329     $ 9,329  
                 
Total Revenues   $ 10,329     $ 9,329  
                 
Operating Expenses                
General and Administrative     4,055       1,115  
Professional fees     7,025       8,100  
Salaries and wages     -       110,000  
Total Operating Expenses     11,080       119,215  
                 
Loss from operations     (751 )     (109,886 )
Other income (expenses)                
Interest expense     (737 )     (896 )
Loss before Income Taxes     (1,488 )     (110,782 )
                 
Income Taxes Expense     1,990       1,764
                 
NET LOSS   $ (3,478 )   $ (112,546 )
                 
Weighted average number of common shares outstanding                
Basic     3,292,945       2,379,902  
Dilutive     3,292,945       2,379,902  
                 
Basic earnings per share                
Dilutive earnings per share   $ (0.0011 )   $ (0.0473 )
    $ (0.0011 )   $ (0.0473 )
                 
OTHER COMPREHENSIVE LOSS                
Net loss   $ (3,478 )   $ (112,546 )
Foreign Currency Translation Adjustments   $ 25,488     $ (22,968 )

TOTAL COMPREHENSIVE INCOME (LOSS)

  $ 22,010     $ (135,514 )

 

See accompanying notes to condensed unaudited consolidated financial statements.

 

2

 

             

ADVANCED OXYGEN TECHNOLOGIES INC. AND SUBSIDIARIES

CONSOLIDATED STATEMENTS OF STOCKHOLDERS’ EQUITY

Three-Month Period Ending September 30, 2020 and 2019

(Unaudited)

 

    Preferred Stock Convertible Series 2     Common
Stock
    Additional
Paid In
    Accumulated    

Accumulated

Other Comprehensive

    Total Stockholders’  
    Shares     Amount     Shares     Amount     Capital     Deficit     Income     Equity  
Balance at June 30, 2019     5,000       50       2,292,945       22,929       20,953,991       (20,724,241 )     48,198       300,927  
To Record the stock-based compensation issuance of 1,000,000 shares of common stock, par value $0.01     -       -       1,000,000       10,000       100,000       -       -       110,000  
Net loss     -       -       -       -       -       (112,546 )             (112,546 )
Foreign Currency Translation Adjustment     -       -       -       -       -       -       (22,968 )     (22,968 )
                                                                 
Balance at September 30, 2019     5,000       50       3,292,945       32,929       21,056,991       (20,836,787 )     25,230       275,413  
                                                                 
Balance at June 30, 2020     5,000       50       3,292,945       32,929       21,057,116       (20,827,344 )     43,226       305,977  
Net loss     -       -       -       -       -       (3,478 )     -       (3,478 )
Foreign Currency Translation Adjustment     -       -       -       -       -       -       25,488       25,488  
                                                                 
Balance at September 30, 2020     5,000       50       3,292,945       32,929       21,057,116       (20,830,822 )     68,714       327,987  

 

See accompanying notes to condensed unaudited consolidated financial statements.

 

3

 

 

ADVANCED OXYGEN TECHNOLOGIES, INC. 

AND SUBSIDIARIES

CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS

(Unaudited) 

 

    For the Three Months Ended September 30,  
    2020     2019  
Cash flows from operating activities:                
                 
Net loss   $ (3,478 )     (112,546 )
Adjustments to reconcile net loss to net cash                
Stock-based compensation     -       110,000  
Expenses paid by a related party     7,479       6,000  
Accounts payable     3,236       2,800  
Taxes payable     4,572       695  
                 
Net cash provided by operating activities     11,809       6,949  
                 
                 
Cash flow from financing activities:                
Repayment of related party debt     (6,849 )     (4,273 )
Repayment of long-term debt     (4,591 )     (6,030 )
Net cash used in financing activities     (11,440 )     (10,303 )
Change due to FX Translation     1,617       (1,720 )
NET CHANGE IN CASH     1,986       (5,074 )
                 
Cash at beginning of year   $ 43,603     $ 43,098  
Cash at end of year   $ 45,589     $ 38,024  
Non Cash Investing and Financing Activities                
Cash paid for Interest     737       896  
Cash paid for Income taxes     -       -  

 

See accompanying notes to condensed unaudited consolidated financial statements.

 

4

 

 

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

 

NOTE 1- ORGANIZATION AND LINE OF BUSINESS:

 

Organization:

 

Advanced Oxygen Technologies Inc, (“Advanced Oxygen Technologies”, “AOXY”, or the “Company”), was incorporated in Delaware in 1981 under the name Aquanautics Corporation and was, from 1985 until May 1995, a startup stage specialty materials company producing new oxygen control technologies. From May of 1995 through December of 1997 the Company had minimal operations and was seeking funding for operations and companies to which it could merge or acquire. In March of 1998 the Company began operations again in California. From 1998 through 2000, the business produced and sold CD- ROMS for conference events, advertisement sales on the CD’s, database management and event marketing all associated with conference events. From 2000 through March of 2003, the business consisted solely of database management. From 2003 through April 2005, the business operations were derived totally from the Company’s wholly owned business, IP Service, ApS, a Danish IP security vulnerability company (“IP Service”). Since then, business operations have been solely derived from its wholly owned subsidiaries Anton Nielsen Vojens, ApS (“ANV”), Sharx Inc. and its wholly owned subsidiary Sharx DK ApS (collectively “Sharx”).

 

Lines of Business:

 

Advanced Oxygen Technologies, Inc. operations are derived from its wholly owned subsidiaries Anton Nielsen Vojens, ApS (“ANV”), Sharx Inc. and its wholly owned subsidiary Sharx DK ApS (collectively “Sharx”).

 

ANV is a Danish company that owns commercial real estate in Vojens, Denmark. ANV’s revenues are derived solely from the lease revenue from its real estate. Circle K Denmark A/S, formerly StatOil A/S, leases the facility from ANV. The lease expires in 2026.

 

Sharx Inc. is a Wyoming corporation incorporated in 2020 and operations are derived from its wholly owned subsidiary Sharx Dk ApS.

 

Sharx DK ApS is a Danish company, incorporated in 2020. On June 30, 2020, Sharx DK ApS, entered into a Distribution Agreement with Cleaver ApS, a Danish corporation (“Cleaver”), whereby Cleaver has appointed the Company as Cleaver’s nonexclusive distributor of its products in Europe, South America and North America. Cleaver is a manufacturer of a line of products for the logistics and cargo industry. 

 

NOTE 2 - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES:

 

Principles of Consolidation:

 

The accompanying consolidated financial statements include the accounts of the Company and its wholly owned subsidiaries (ANV and Sharx), after elimination of all intercompany accounts, transactions, and profits.

 

Basis of Presentation:

 

The consolidated financial statements of the Company have been prepared in accordance with U.S. GAAP and are expressed in United States dollars. The Company’s fiscal year end is June 30.

 

Revenue Recognition:

 

Revenue from Contracts with Customers

For our rental revenue and commission revenue, we recognize revenue under the five steps in Topic 606, which are as follows: 1) identify the contract with the customer; 2) identify the performance obligations in the contract; 3) determine the transaction price; 4) allocate the transaction price to the performance obligations; and 5) recognize revenue when (or as) performance obligations are satisfied.

 

5

 

 

Rental Revenue

Revenue was not affected materially in any period due to the adoption of ASC Topic 606 because: (1) we identified similar performance obligations under ASC Topic 606 as compared with deliverables and separate units of account previously identified; our performance obligation is to provide the land; (2) we determined the transaction price to be consistent; the lease agreement with the customer specifies the transaction price; and (3) we recorded revenue at the same point in time, upon delivery under both ASC Topic 605 and ASC Topic 606, as applicable under the terms of the contract with the customer. Additionally, the accounting for fulfillment costs or costs incurred to obtain a contract were not affected materially in any period due to the adoption of Topic 606.

 

Lastly, disclosure requirements under the new guidance in Topic 606 have been significantly expanded in comparison to the disclosure requirements under the current guidance, including disclosures related to disaggregation of revenue into appropriate categories, performance obligations, the judgments made in revenue recognition determinations, adjustments to revenue which relate to activities from previous quarters or years, any significant reversals of revenue, and costs to obtain or fulfill contracts.

 

The rental revenue is derived from the Commercial Property lease in which quarterly payments are received pursuant to the property lease which is in effect until 2026. (See Note 3 for further details) and from the sale of product pursuant to a non-exclusive distribution agreement. We recognize revenue when we have satisfied a performance obligation by transferring control over a product or delivering a service to a client. We measure revenue based upon the consideration set forth in an arrangement or contract with a client. We recognize revenue from these services when the services are completed. If we are paid in advance for these services, we record such payment as deferred revenue until we complete the services. As of September 30, 2020, the Company recorded $3,291 of deferred revenue in connection to rental revenues.

 

Commission revenue

The Company recognizes commission revenue based on the five criteria for revenue recognition established under Topic 606: 1) identify the contract, 2) identify separate performance obligations, 3) determine the transaction price, 4) allocate the transaction price among the performance obligations, and 5) recognize revenue as the performance obligations are satisfied as set forth below.

 

The Company’s source of commission revenue is from the Company’s subsidiary Sharx in which quarterly payments are received when the customer pre-pays or pays upon the date products are drop shipped from the manufacturer pursuant to a non-exclusive distribution agreement. At such time the products are drop shipped, the Company’s performance obligation has been satisfied and revenue is recorded The Company has determined that it is an agent of the manufacturer and collects commission revenue at or before the delivery of product (See Note 3 for further details).

 

Property Plant and Equipment:

 

Land is recognized at cost. Land is carried at cost less accumulated impairment losses.

 

Foreign currency translation:

 

Foreign currency transactions are translated applying the current rate method. Assets and liabilities are translated at current rates. Stockholders’ equity accounts are translated at the appropriate historical rates and revenue and expenses are translated at weighted average rates for the year. Exchange rate differences that arise between the rate at the transaction date and the one in effect at the payment date, or at the balance sheet date, are recognized in the income statement.

 

Foreign currency transactions:  

 

The Company applies the guidelines as set out in Section 830-20-35 of the FASB Accounting Standards Codification (“Section 830-20-35”) for foreign currency transactions. Pursuant to Section 830-20-35 of the FASB Accounting Standards Codification, foreign currency transactions are transactions denominated in currencies other than U.S. Dollar, the Company’s reporting currency. Foreign currency transactions may produce receivables or payables that are fixed in terms of the amount of foreign currency that will be received or paid. A change in exchange rates between the reporting currency and the currency in which a transaction is denominated increases or decreases the expected amount of reporting currency cash flows upon settlement of the transaction. That increase or decrease in expected reporting currency cash flows is a foreign currency transaction gain or loss that generally shall be included in determining net income for the period in which the exchange rate changes. Likewise, a transaction gain or loss (measured from the transaction date or the most recent intervening balance sheet date, whichever is later) realized upon settlement of a foreign currency transaction generally shall be included in determining net income for the period in which the transaction is settled. The exceptions to this requirement for inclusion in net income of transaction gains and losses pertain to certain intercompany transactions and to transactions that are designated as, and effective as, economic hedges of net investments and foreign currency commitments. Pursuant to Section 830-20-25 of the FASB Accounting Standards Codification, the following shall apply to all foreign currency transactions of an enterprise and its investees: (a) at the date the transaction is recognized, each asset, liability, revenue, expense, gain, or loss arising from the transaction shall be measured and recorded in the functional currency of the recording entity by use of the exchange rate in effect at that date as defined in section 830-10-20 of the FASB Accounting Standards Codification; and (b) at each balance sheet date, recorded balances that are denominated in currencies other than the functional currency or reporting currency of the recording entity shall be adjusted to reflect the current exchange rate.

 

6

 

 

The Company’s wholly owned subsidiary ANV uses the Danish Krone, DKK as its reporting currency as well as its functional currency The wholly owned subsidiary Sharx DK ApS uses the US Dollar as its reporting currency as well as its functional currency and from time to time has transactions in foreign currency. The change in exchange rates between the U.S. Dollar, the Company’s reporting and functional currency and the foreign currency, the currency in which a transaction is denominated increases or decreases the expected amount of reporting currency cash flows upon settlement of the transaction. That increase or decrease in expected reporting currency cash flows is a foreign currency transaction gain or loss that generally is included in determining net income (loss) for the period in which the exchange rate changes.

 

Income Taxes:

 

The Company accounts for income taxes under the asset and liability method of accounting. Under this method, deferred tax assets and liabilities are recognized for the future tax consequences attributable to differences between the financial statement carrying amounts of existing assets and liabilities and their respective tax bases. Deferred tax assets and liabilities are measured using enacted tax rates expected to apply to taxable income in the years in which those temporary differences are expected to be recovered or settled. The effect on deferred tax assets and liabilities of a change in tax rates is recognized in income in the period that includes the enactment date. A valuation allowance is required when it is less likely than not that the Company will be able to realize all or a portion of its deferred tax assets. Because it is doubtful that the net operating losses of recent years will ever be used, a valuation allowance has been recognized equal to the tax benefit of net operating losses generated.

 

Earnings per Share:

 

Basic earnings per share is computed by dividing income available to common shareholders by the weighted-average number of common shares available. Diluted earnings per share is computed similar to basic earnings per share except that the denominator is increased to include the number of additional common shares that would have been outstanding if the potential common shares had been issued and if the additional common shares were dilutive. As of September 30, 2020, and September 30, 2019 there were 10,000 and 10,000, potential dilutive shares that need to be considered as common share equivalents and because of the net loss, the effect of these potential common shares is anti-dilutive for three-months ended September 30, 2020 and September 30, 2019respectively and therefore not included in the computation of dilutive shares.

 

Cash and Cash Equivalents:

 

For purposes of the statement of cash flows, the Company considers all highly-liquid investments purchased with original maturities of three months or less to be cash equivalents.

 

The Company maintains its cash in bank deposit accounts which, at September 30, 2020 did not exceed federally insured limits. The Company has not experienced any losses in such accounts and believes that it is not exposed to any significant credit risk on such amounts.

 

Stock-Based Compensation:

 

The Company records stock-based compensation in accordance with ASC 718, Compensation. All transactions in which goods or services are the consideration received for the issuance of equity instruments are accounted for based on the fair value of the consideration received or the fair value of the equity instrument issued, whichever is more reliably measurable. Equity instruments issued to employees and the cost of the services received as consideration are measured and recognized based on the fair value of the equity instruments issued and are recognized over the employees required service period, which is generally the vesting period.

 

Estimates:

 

The preparation of the condensed consolidated financial statements in conformity with generally accepted accounting principles requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosures of contingent assets and liabilities at the date of the condensed consolidated financial statements, as well as the reported amounts of revenue and expenses during the reported period. Actual results could differ from those estimates.

 

Concentrations of Credit Risk:

 

Financial instruments that potentially subject the Company to major credit risk consist principally of a single subsidiary of Anton Nielsen Vojens ApS. ANV’s rent revenues are derived from one customer. The Company’s commission revenues are subject to concentration risk as the commission revenues are derived from one product, and one customer, but that should not be the case going forward.

 

7

 

 

Leases:

 

The Company leases land to a customer. The Company determines if an arrangement contains a lease at contract inception. An arrangement is or contains a lease if the agreement identifies an asset, implicitly or explicitly, that the Customer has the right to use over a period of time. If an arrangement contains a lease, the Company classifies the lease as either an operating lease or as a finance lease based on the five criteria defined in ASC 842.

 

Lease liabilities are recognized at commencement date based on the present value of the remaining lease payments over the lease term. The corresponding right-of-use asset is recognized for the same amount as the lease liability adjusted for any payments made at or before the commencement date, any lease incentives received, and any initial direct costs. The Company’s lease agreements may include options to renew, extend or terminate the lease. These clauses are included in the initial measurement of the lease liability when at lease commencement the Company is reasonably certain that it will exercise such options. The discount rate used is the interest rate implicit in the lease or, if that cannot be readily determined, the Company’s incremental borrowing rate.

 

Operating lease expense is recognized on a straight-line basis over the lease term and presented within cost of sales on the Company’s consolidated statements of operations. Finance lease right-of-use assets are amortized on a straight-line basis over the shorter of the useful life of the asset or the lease term. Interest expense on the finance lease liability is recognized using the effective interest rate method and is presented within interest expense on the Company’s consolidated statements of operations and comprehensive income. Variable rent payments related to both operating and finance leases are expensed as incurred. The Company’s variable lease payments primarily consists of real estate taxes, maintenance and usage charges. The Company made an accounting policy election to combine lease and non-lease components.

 

The Company has elected to exclude short-term leases from the recognition requirements of ASC 842. A lease is short-term if, at the commencement date, it has a term of less than or equal to one year. Lease expense related to short-term leases is recognized on a straight-line basis over the lease term.

 

8

 

 

Recently Issued Accounting Standards:   

 

None. 

 

In August 2018, the FASB issued ASU 2018-13, Fair Value Measurement (Topic 820), Disclosure Framework - Changes to the Disclosure Requirements for Fair Value Measurements. This ASU includes additional disclosures requirements for recurring Level 3 fair value measurements including disclosure of changes in unrealized gains and losses for the period included in other comprehensive income, disclosure of the range and weighted average of significant unobservable inputs used to develop Level 3 fair value measurements and narrative description of measurement uncertainty related to Level 3 measurements. The Company adopted this Fair Value Measurement and it has not had a material impact on the Company’s financial statements.

 

New Accounting Pronouncements Not Yet Adopted

 

In December 2019, the FASB issued ASU No. 2019-12, Income Taxes (Topic 740)—Simplifying the Accounting for Income Taxes. ASU 2019-12 is intended to simplify accounting for income taxes. It removes certain exceptions to the general principles in Topic 740 and amends existing guidance to improve consistent application. ASU 2019-12 is effective for fiscal years beginning after December 15, 2020 and interim periods within those fiscal years, which is fiscal 2022 for us, with early adoption permitted. We do not expect adoption of the new guidance to have a significant impact on our financial statements.

In August 2018, the FASB issued ASU 2018-13, “Disclosure Framework - Changes to the Disclosure Requirements for Fair Value Measurement.” ASU 2018-13 modifies the fair value measurements disclosures with the primary focus to improve effectiveness of disclosures in the notes to the financial statements that is most important to the users. The new guidance modifies the required disclosures related to the valuation techniques and inputs used, uncertainty in measurement, and changes in measurements applied. ASU 2018-13 will be effective for the Company for its fiscal year beginning after December 15, 2019 and each quarterly period thereafter. Early adoption is permitted. The Company is currently assessing the impact this new guidance may have on the Company’s consolidated financial statements and footnote disclosures.

 

Other recent accounting pronouncements issued by the FASB did not or are not believed by management to have a material impact on the Company’s present or future financial statements.

 

9

 

 

NOTE 3 - REVENUE:

 

The Company’s subsidiary, Anton Nielsen Vojens, ApS has one customer who is a non-related party and leases property from the Company. Rent revenues related to the operating lease are recognized as incurred. The Company’s subsidiary Sharx DK ApS derived its commission revenues from the sales of cargo security product from one customer. The Company has determined that it is an agent of the manufacturer and collects commission revenue eat or before the delivery of product.

 

The Company disaggregates revenues by revenue type and geographic location. See the below tables:

 

    Three Months Ended September 30,  
Revenue Type   2020     2019  
Real Estate Rental   $ 10,329     $ 9,329  
Commission Revenues     -       -  
Total Sales by Revenue Type   $ 10,329     $ 9,329  

 

The Company’s derives revenues from 100% of foreign customer. For the period ending September 30, 2020 and September 30, 2019 the major geographic concentrations were as follows:

 

    Foreign Sales for the Three Months Ended September 30,  
Revenue Type   2020     2019  
Real Estate Rental Revenues   $ 10,329     $ 9,329  
Commission Revenues     -       -  
Total Sales by Geographic Location   $ 10,329     $ 9,329  

 

NOTE 4–PROPERTY AND EQUIPMENT:

 

The Land owned by the Company’s wholly owned subsidiary constitutes the largest asset of the Company. During the period ending September 30, 2020 the Company recorded an increase in the carrying value of the Land of $27,363, due to the currency translation difference. The carrying value of the Land of the Company was as follows:

 

   

 Carrying Value of

Land at

 
    September 30,
2020
    June 30, 2020  
US Dollars   $ 636,613     $ 609,250  

 

10

 

 

NOTE 5 - RELATED PARTY TRANSACTIONS: 

 

Crossfield, Inc., a company of which the CEO, Robert Wolfe is an officer and director, has made advances to the Company which are not collateralized, non-interest bearing, and payable upon demand; however, the Company did not expect to make payment within one year. At September 30, 2020 and June 30, 2020, the Company had a balance of $120,047 and $120,271 respectively. During the three-month period ended September 30, 2020 and June 30,2019expenses paid on behalf of the Company were $7,479 and $6,000 respectively. The Company repaid $6,849 of the advancement during the three months ending September 30, 2020.

 

NOTE 6 - NOTES PAYABLE:

 

During 2006, the Company issued a promissory note (“Note”) for $650,000, payable to the Borkwood Development Ltd, a previous shareholder of the Company (“Seller”), payable and amortized monthly and carrying an interest at 5% per year. The Company has the right to prepay the note at any time with a notice of 14 days. To secure the payment of principal and interest the Sellers will receive a perfect lien and security interest in the Shares in the company ANV until the note with accrued interest is paid in full, and, 2) In the case that the Note has not been repaid within 12 months from the day of closing the Sellers have the right to convert the debt to common stock of Advanced Oxygen Technologies, Inc. in an amount of non-diluted shares calculated on the conversion Date, equal to the lesser of : a) Six hundred and Fifty thousand (650,000) or the Purchase Price minus the principal payments made by the buyer, whichever is greater, divided by the previous ten day closing price of AOXY as quoted on the national exchange, or b) Fifteen million shares, whichever is lesser. The Note has been extended until July 1, 2020, prior to period end and interest waived through the period ending June 30, 2021. Due to the extension, the note is not in default and therefore not convertible as of September 30, 2020. As of September 30, 2020, the unpaid balance was $127,029.

 

The Company has a note payable with a bank (“Note B”). The original amount of Note B was kr 1,132,000 Danish Krone (kr). Note B is secured by the subsidiary’s real estate, with a 2.00% interest rate and 3.2 years remaining on the term. The balance on the note as of September 30, 2020 was $59,752. During the period ended September 30, 2020, the Company paid $4,591in principal payments and $737 in interest.

 

The Company’s commitments and contingencies are $141,008 for 2020. See below table for the years 2020 through 2024 with a total of $186,781. The amounts stated reflect the Company’s commitments in the currencies that those commitments were made and the amounts are an estimate of what the US dollar amount would be if the currency rates did not change.

 

Year   Amount  
2021   $ 141,008  
2022     18,967  
2023     19,349  
2024     7,456  
Total   $ 186,781  
Less: Long-term portion of notes payable     (41,798 )
Notes payable, current portion   $ 144,983  

 

The amounts stated in this note reflect the Company’s commitments in the currencies that those commitments were made and the amounts are an estimate of what the US dollar amount would be if the currency rates did not change going forward.

 

11

 

 

NOTE 7 - STOCKHOLDERS’ EQUITY:

 

Common Stock:

 

On September 23, 2019 the Company entered into a Stock Grant and Investment Agreement with Robert Wolfe, its CEO and a Director (“Wolfe”) whereby the Company has granted 1,000,000 shares (the “Shares”) of common stock of the Company, with a fair value of $110,000based on a stock price of $0.11. The shares were issued for services rendered by Wolfe to the Company and which Shares are deemed irrevocably and fully earned and vested as of the date thereof. The Shares have been issued in reliance upon the exemption from registration pursuant to Section 4(a)(2) of the Securities Act of 1933, as amended.

 

Preferred Stock:

 

Series 2 Convertible Preferred Stock:

 

The Company is authorized to issue 10,000,000 shares of $0.01 par value of series 2 convertible preferred stock. The Company may issue any class of preferred shares in series. The board of directors has the authority to establish and designate series and to fix the number of shares included in each such series. Each Series 2 preferred share is convertible into two shares of common stock at the option of the holder.

 

Series 2 Convertible Preferred Stock:

 

Each Series 2 preferred share also includes one warrant to purchase two common shares for $5.00. The warrants are exercisable over a three-year period. In the event of the liquidation of the Company, holders of Series 2 preferred stock would be entitled to receive $5.00 per share, plus any unpaid dividends declared on the Series 2 preferred stock from the funds remaining after the Company’s creditors, including directors, have been paid. There have been no dividends declared. There are 177,000 Series 2 Convertible Preferred shares designated. During November 1997, 172,000 shares of Series 2 preferred stock were converted into 344,000 shares of the Company’s common stock. As of September 30, 2020, and June 30, 2020 there are 5,000 shares issued, which are convertible into 2 common shares. There are no warrants outstanding that have been issued in connection with these preferred shares.

 

Series 3 Convertible Preferred Stock:

 

The Company has designated 1,670,000 shares of series 3 convertible preferred stock with a par value $0.01. Each share automatically converts on March 2, 2000 into either (a) one (1) share of the Company’s common stock if the average closing price of the common stock during the ten trading days immediately prior to March 1, 2000 is equal to or greater than sixty-six cents ($0.66) per share, or (b) one and one-half (1 1/2) shares of common stock if the average closing price of the common stock during the ten trading days immediately prior March 1, 2000 is less than sixty-six cents ($0.66) per share. There are zero shares issued and outstanding at September 30, 2020 and June 30, 2020.

 

12

 

 

Series 5 Convertible Preferred Stock:

 

The Company has designated 1 share of series 5 convertible preferred stock, no par value. There is 1 Series 5 Convertible Preferred shares designated. The shares are collectively convertible to common stock of the Company on March 5, 2004, in an amount equal to the greater of a.)290,000 shares divided by the ten day closing price, prior to the date of acquisition of IPS, of the Company’s common stock as quoted on the national exchange and not to exceed twenty million shares, or b.) six million shares. There are zero shares issued and outstanding at September 30, 2020 and June 30, 2020.

 

NOTE 8 - Segment and Geographic Information

 

Segment Performance

 

We have three reporting segments:

 

The ANV lease segment which leases land in Denmark by long term leases.
The Sharx’s segment which generate commissions for the sale cargo security products.
The Corporate segment, Advanced Oxygen Technologies, Inc. which does not generate revenues, but has administrative expenses.

 

The following table summarizes financial information regarding each reportable segment’s results of operations for the periods presented:

 

    Three Months Ending September 30,  
    2020     2019  
             
Revenue by segment                
ANV lease revenues   $ 10,329     $ 9,239  
Sharx commission revenues from security product sales     -       -  
Corporate segment revenues     -       -  
Total revenue   $ 10,329     $ 9,329  
                 
Segment profitability                
ANV lease revenues   $ 7,053     $ 6,254  
Sharx commission revenues from security product sales     184       -  
Corporate segment     (10,715 )     (118,800 )
Total segment profitability   $ (3,478 )   $ (112,546 )
                 

The following table presents net sales, based on the location in which the sale originated, and long-lived assets, representing property, plant and equipment, net of related depreciation, by geographic region. All of the assets are land that are held by the Company’s subsidiary, ANV.

 

Three Months Ending September 30:   2020     2019  
Net Sales                
United States   $ -     $ -  
Denmark     10,329       9,329  
Total   $ 10,329     $ 9,329  
                 
As of September 30, 2020 and June 30, 2020                
Long-Lived Assets                
United States   $ -     $ -  
Denmark     636,613       609,250  
Total   $ 636,613     $ 609,250  

 

13

 

 

Three Months Ending September 30, 2020
    ANV     Sharx     Corporate     Total  
                         
Net sales   $ 10,329     $ -     $ -     $ 10,602  
Operating income (loss)     9,780       184       (10,715 )     (751 )
Interest expense     (737 )     -       -       (737 )
Total assets   $ 675,644     $ 7,663     $ 150     $ 683,457  

 

Three Months Ending September 30, 2019
    ANV     Sharx     Corporate     Total  
                         
Net sales   $ 9,329     $ -     $ -     $ 9,329  
Operating (loss) income     8,914       -       (118,800 )     (109,886 )
Interest expense     (896 )     -       -       (896 )
Total assets   $ 628,630     $     -     $ 150     $ 628,780  

 

NOTE 9 - SUBSEQUENT EVENTS: 

 

In accordance with ASC 855-10, Company management reviewed all material events through the date of this report.

 

14

 

 

ITEM 2: MANAGEMENT’S DISCUSSION AND ANALYSIS OR PLAN OF OPERATION.

 

The following should be read in conjunction with our Consolidated Financial Statements and the notes thereto included in the Financial Statements.

 

FORWARD LOOKING STATEMENTS:

 

Certain statements contained in this report, including statements concerning the Company’s future and financing requirements, the Company’s ability to obtain market acceptance of its products and the competitive market for sales of small production business and other statements contained herein regarding matters that are not historical facts, are forward looking statements; actual results may differ materially from those set forth in the forward looking statements, which statements involve risks and uncertainties, including without limitation to those risks and uncertainties set forth in any of the Company’s Registration Statements under the heading “Risk Factors” or any other such heading. In addition, historical performance of the Company should not be considered as an indicator for future performance, and as such, the future performance of the Company may differ significantly from historical performance.

 

Revenues: Revenues from operations for the three-month period ending September 30, 2020 and September 30, 2019 were $10,329 and $9,329 respectively. The increase was attributable to currency fluctuations.

 

General and administrative expenses: G&A expenses for the three-month period ending September 30, 2020 and September 30, 2019 were $4,055 and $1,115 respectively. The expenses are mainly attributable to ANV’s normal operations and the Company’s SEC compliance and the fluctuations are attributable to currency fluctuations and accounting costs.

 

Salary and Wages expenses: Salary and wage compensation expenses for the three-month period ending September 30, 2020 and September 30, 2019 were $0 and $110,000 respectively. The decrease was due to a one-time stock grant to an officer of the Company.

 

Professional expenses: Professional expenses for the three-month period ending September 30, 2020 and September 30, 2019 were $7,025, and $8,100 respectively. The expenses were attributable to the ordinary audit and attributable to transfer agent fees for 2020 and 2019.

 

Interest expense: Interest expense for the three-month period ending September 30, 2020 and September 30, 2019 was $(737) and $(896) respectively. Interest expenses for 2020 are lower primarily due to the currency fluctuations and the reduction of debt.

 

Net loss: Net loss attributed to common stockholders was $(3,478) or $(0.0011) per share for the three-month period ending September 30, 2020 as compared to $(112,546) or $(0.0473) per share for September 30, 2019. The fluctuations are mainly attributable to officer compensation, general & administrative expenses and currency fluctuations.

 

15

 

 

Liquidity and capital resources: At September 30, 2020 and June 30, 2020, the Company had cash and cash equivalents of $45,589 and $43,603 respectively. At September 30, 2020 and June 30, 2020, the Company had a working capital deficit of $266,828 and $258,857 respectively. The change in cash is primarily due to the ANV’S payment of debt and normal operations. The increase in the working capital is primarily related to the operations of the Subsidiary.

 

Net cash provided by operating activities for three-month period ending September 30, 2020 and September 30, 2019 was $11,809 and $6,949, respectively. The increase was primarily the increase in taxes, legal fees and expenses paid on behalf on a related party.

 

Net cash used-in financing activities for three-month period ending September 30, 2020 and September 30, 2019 was $(11,440) and $(10,303) respectively. Net cash provided from or used for financing activities for both periods is related to the company’s borrowings from banks, officers and directors, and the repayment of debt.

 

OFF BALANCE SHEET ARRANGEMENTS:

 

We do not currently have any off-balance sheet arrangements.

 

ACQUISITION EFFORTS:

 

The Company continues its efforts to raise capital to support operations and growth and is actively searching acquisition or merger with another company that would complement AOXY or increase its earnings potential. During this period, the Company has been in discussion with Companies looking to be acquired. AOXY has not negotiated any terms nor proposed any acquisitions of any of these companies that have been accepted. In addition, the Company is in discussion with potential lending institutions to assist in financing any proposed acquisition. The Company expects difficulty in financing the growth of the increased business or acquisition and has been concentrating on raising capital and/or obtaining a line of credit.

 

ITEM 3. Quantitative and Qualitative Disclosures About Market Risk:

 

Smaller reporting companies are not required to provide the information required by this Item.

 

ITEM 4. CONTROLS AND PROCEDURES

 

EVALUATION OF DISCLOSURE CONTROLS AND PROCEDURES

 

We conducted an evaluation under the supervision and with the participation of our management, including our Chief Executive Officer who is also our Chief Financial Officer, of the effectiveness of the design and operation of our disclosure controls and procedures. The term “disclosure controls and procedures”, as defined in Rules 13a-15(e) and 15d-15(e) under the Securities and Exchange Act of 1934, as amended (“Exchange Act”), means controls and other procedures of a company that are designed to ensure that information required to be disclosed by the company in the reports it files or submits under the Exchange Act is recorded, processed, summarized and reported, within the time periods specified in the Securities and Exchange Commission’s rules and forms. Disclosure controls and procedures also include, without limitation, controls and procedures designed to ensure that information required to be disclosed by a company in the reports that it files or submits under the Exchange Act is accumulated and communicated to the company’s management, including its principal executive and principal financial officers, or persons performing similar functions, as appropriate, to allow timely decisions regarding required disclosure. Based on this evaluation, our Chief Executive Officer and Acting Chief Financial Officer concluded as of September 30, 2020 that our disclosure controls and procedures were not effective at ensuring that the material information required to be disclosed in the Exchange Act reports is recorded, processed, summarized and reported as required in applicable SEC rules and forms.

 

Changes in Internal Control over Financial Reporting

 

During the three-month period ended September 30, 2020, there were no changes in our internal control over financial reporting identified in connection with managements evaluation of the effectiveness of our internal control over the financial reporting that have materially affected, or are reasonably likely to materially affect, our internal control over financial reporting as defined in Rules 13a-15(f) and 15d-15(f) under the Exchange Act.

 

16

 

 

PART II

 

ITEM 1: LEGAL PROCEEDINGS

 

During the period ending September 30, 2020, there were pending or threatened legal actions as follows:

 

None

 

ITEM 2. UNREGISTERED SALES OF EQUITY SECURITIES AND USE OF PROCEEDS

 

None

 

ITEM 3. DEFAULTS UPON SENIOR SECURITIES

 

None

 

ITEM 4. MINE SAFETY DISCLOSURES

 

None

 

ITEM 5. OTHER INFORMATION

 

None 

 

17

 

  

ITEM 6: EXHIBITS AND REPORTS ON FORM 8-K

 

During three- month period ending September 30, 2020, the Company filed no reports on Form 8-K.

 

Exhibit Number   Description of the Document
3.1   Certificate of Incorporation as Amended and filed with the Secretary of State of Delaware effective on December 5, 2014
3.2   Bylaws. (Previously Filed)
31.1*   Certification of Chief Executive Officer pursuant to Exchange Act Rule 13a-14(a)/15d-14(a), as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.
31.2*   Certification of Chief Financial Officer pursuant to Exchange Act Rule 13a-14(a)/15d-14(a), as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.
32.1*   Certification of Chief Executive Officer in accordance with 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.
32.2*   Certification of Chief Financial Officer in accordance with 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.
10.1   Stock Grant and Investment Agreement dated September 23, 2019
101.INS   XBRL Instance
101.SCH   XBRL Taxonomy Extension Schema Document
101.CAL   XBRL Taxonomy Extension Calculation Linkbase Document
101.DEF   XBRL Taxonomy Extension Definition Linkbase Document
101.LAB   XBRL Taxonomy Extension Labels Linkbase Document
101.PRE   XBRL Taxonomy Extension Presentation Linkbase Document

 

* Filed herewith

 

18

 

 

SIGNATURE

 

In accordance with the requirements of the Exchange Act, the Registrant has caused this report to be signed on its behalf by the undersigned, thereunto duly authorized. 

 

Date: October 22, 2020 By: /s/ Robert E. Wolfe
    Robert E. Wolfe
   

Chairman of the Board and Chief Executive Officer and

Principal Financial Officer

 

19

 

Advanced Oxygen Technolo... (PK) (USOTC:AOXY)
Historical Stock Chart
From Feb 2024 to Mar 2024 Click Here for more Advanced Oxygen Technolo... (PK) Charts.
Advanced Oxygen Technolo... (PK) (USOTC:AOXY)
Historical Stock Chart
From Mar 2023 to Mar 2024 Click Here for more Advanced Oxygen Technolo... (PK) Charts.